Kevin Mc Culloch Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Kevin Mc Culloch is Officer of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 1.7 Million shares of XERS, which is worth approximately $13.2 Million. The most recent transaction as insider was on Aug 01, 2025, when has been sold 14,651 shares (Common Stock) at a price of $5.38 per share, resulting in proceeds of $78,822. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.7M

1.04% 3M change

6.19% 12M change

Total Value Held $13.2 Million

Kevin McCulloch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2025	SELL Payment of exercise price or tax liability	$78,822 $5.38 p/Share	14,651 Reduced 0.85%	1,701,159 Common Stock
Jun 13 2025	BUY Open market or private purchase	$109,500 $4.38 p/Share	25,000 Added 1.44%	1,708,585 Common Stock
Apr 02 2025	SELL Payment of exercise price or tax liability	$3,774 $5.15 p/Share	733 Reduced 0.04%	1,683,585 Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$278,157 $3.56 p/Share	78,134 Reduced 4.95%	1,499,318 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	185,000 Added 9.9%	1,684,318 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$88,448 $3.61 p/Share	24,501 Reduced 1.53%	1,577,452 Common Stock
Aug 01 2024	BUY Grant, award, or other acquisition	-	150,000 Added 8.56%	1,601,953 Common Stock

Kevin Mc Culloch

Officer

Chicago, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Value

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Xeris Biopharma Holdings, Inc.

Track Activities on XERS

Account